(1) Repaglinide tablets are not indicated for patients with diabetic ketoacidosis or Type 1 diabetes. It should not be used with gemfibrozil, NPH-insulin or in patients with a known hypersensitivity to the drug.SOURCE Mylan Inc.
Shares in the stock decline only marginally as the pharmaceuticals group sticks with its full-year forecast.
The pain medication maker struck a deal with the fund managed by insurgent Jeff Smith to install a minority-slate of three dissident directors onto its board.
With Clinton apparently headed for victory, worries about her being a threat to health-care stocks have peaked.